[HTML] nature.com

[HTML][HTML] Hippocampal delivery of neurotrophic factor-α1/carboxypeptidase E gene prevents neurodegeneration, amyloidosis, memory loss in Alzheimer's disease …

L Xiao, X Yang, VK Sharma, D Abebe, YP Loh - Molecular Psychiatry, 2023 - nature.com
Alzheimer's Disease (AD) is a prevalent neurodegenerative disease characterized by tau
hyperphosphorylation, Aβ1-42 aggregation and cognitive dysfunction. Therapeutic agents …
被引用次数：6 相关文章

Hippocampal delivery of neurotrophic factor-α1/carboxypeptidase E gene prevents neurodegeneration, amyloidosis, memory loss in Alzheimer's Disease male mice

L Xiao, X Yang, VK Sharma, D Abebe… - Molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
Alzheimer's Disease (AD) is a prevalent neurodegenerative disease characterized by tau
hyperphosphorylation, Aβ1-42 aggregation and cognitive dysfunction. Therapeutic agents …
[HTML] nih.gov

[HTML][HTML] Hippocampal delivery of neurotrophic factor-α1/carboxypeptidase E gene prevents neurodegeneration, amyloidosis, memory loss in Alzheimer's Disease …

L Xiao, X Yang, VK Sharma, D Abebe… - Molecular …, 2023 - ncbi.nlm.nih.gov
Alzheimer's Disease (AD) is a prevalent neurodegenerative disease characterized by tau
hyperphosphorylation, Aβ1-42 aggregation and cognitive dysfunction. Therapeutic agents …

Hippocampal delivery of neurotrophic factor-α1/carboxypeptidase E gene prevents neurodegeneration, amyloidosis, memory loss in Alzheimer's Disease male mice.

L Xiao, X Yang, VK Sharma, D Abebe… - Molecular Psychiatry, 2023 - europepmc.org
Alzheimer's Disease (AD) is a prevalent neurodegenerative disease characterized by tau
hyperphosphorylation, Aβ1-42 aggregation and cognitive dysfunction. Therapeutic agents …

Hippocampal delivery of neurotrophic factor-α1/carboxypeptidase E gene prevents neurodegeneration, amyloidosis, memory loss in Alzheimer's Disease male mice.

L Xiao, X Yang, VK Sharma, D Abebe… - Molecular Psychiatry, 2023 - europepmc.org
Alzheimer's Disease (AD) is a prevalent neurodegenerative disease characterized by tau
hyperphosphorylation, Aβ1-42 aggregation and cognitive dysfunction. Therapeutic agents …